Psyence Biomedical (PBM) Change in Cash (2023)

Psyence Biomedical (PBM) recorded quarterly Change in Cash of -$419157.0 in Q1 2023.

Psyence Biomedical (PBM) Change in Cash (2023) Analysis & Trends

Psyence Biomedical's Change in Cash history runs 1 years deep, the most recent figure standing at -$419157.0 for Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 2.44 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 623.00 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -2.44 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 417.10 Mn
9 Abivax 94.26 Bn 94.26 Bn - -45.97 Mn
10 Regeneron Pharmaceuticals 66.09 Bn 57.33 Bn 3.31 Bn -153.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 -419,157.00